Treatment results of osteogenic sarcoma. An evaluation of 36 patients treated during 30-year period in South-Western Finland

European Journal of Surgical Oncology

Volumn 23, Issue 1, 1997, Pages 54-58

  Pylkkänen, Liisa ^a   Aho, Allan J ^a   Ekfors, Tauno ^a   Salmi, Toivo T ^a   Tuominen, Juhani ^a   Viljanto, Jouko ^a   Nikkanen, Väinämö ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Adjuvant chemotherapy; Limb salvage surgery; Osteogenic sarcoma; Surgery

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FINLAND; HISTOLOGY; HUMAN; HUMAN TISSUE; KNEE; LIMB SALVAGE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL TIME;

EID: 0031029602     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)80143-6     Document Type: Article

References (30)

1. Friedman MA, Carter SK. The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol 1972; 4: 482-50.
2. Jussila P. Primary malignant bone tumors. A retrospective study of 869 cases reported to the Finnish Cancer Registry between 1962 and 1968. Acta Orthop Scand (Suppl) 1980; 182.
3. Larsson S-E, Lorentzon R, Wedrén H, Boquist L. Prognostic factors in osteosarcoma diagnosed in Sweden 1958-1968. Abstr. Scandinavian Symposium on Bone Tumors. 1981. University of Umeå, S-901 85 Umeå, Sweden.
4. Harvei S, Solheim O. The prognosis in osteosarcoma: Norwegian national data. Cancer 1981; 48: 1719-23.
5. Goorin A. Abelson H, Frei E. Medical progress. Osteosarcoma: fifteen years later. N Engl J Med 1985; 26: 1637-42.
6. Eilber FR, Rosen G. Adjuvant chemotherapy for osteosarcoma. Semin Oncol 1989; 16: 312-23.
7. Elomaa I, Siimes M, Blomqvist C, Karaharju E, Ryöppy S, Laaksonen E, Holmström T. Ten years' experience in patients with osteogenic sarcoma in Finland. Eur J Surg Oncol 1990; 16: 147-52.
8. Saeter G, Alvegård T, Elomaa I, Stenwig A, Holmstro̊m T, Solheim O. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effect of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group Study. J Clin Oncol 1991; 9: 1766-75.
9. Link M, Goorin A, Horowitz M, et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the multi-institutional osteosarcoma study. Clin Orthop Rel Res 1991; 270: 8-14.
10. Glasser D, Lane J, Huvos A, Marcove R, Rosen G. Survival, prognosis, and therapeutic response in oesleogenic sarcoma. The Memorial Hospital experience. Cancer 1992; 69: 698-708.
11. Mȩyers P. Heller G, Huvos A. et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the memorial Sloan-Kettering Experience. J Clin Oncol 1982; 10: 5-15.
12. Bacci G, Picci P, Ruggeri, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Instituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate dose) in intra-arterial cisplatin. Cancer 1990; 65: 2539-53.
13. Gebhart MC, Flugstad DI. Spingfield DS, Mankin HJ. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Rel Res 1991; 270: 181-96.
14. Enneking WF. Staging musculosceletal tumors. In: Enneking WF (ed.) Musculoskeletal Tumor Surgery. New York: Churchill Livingstone, 1983: 69-88.
15. Rosen G, Tan C, Sanmaneechai A, Beattie E, Marcove R, Murphy ML. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma. Cancer 1974; 35: 936-45.
16. Rosen G, Marcove RC. Caparros B, Nirenberg A. Kosloff C, Huvos A. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 1979; 43: 2163-77.
17. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-30.
18. Larsson S-E, Lorentzon R. The incidence of malignant primary bone tumors in relation to age, sex and site: a study of osteogenic sarcoma, chondrosarcoma and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg (Br) 1974; 56: 534-40.
19. Wuisman P, Enneking WF. Roessner A. Local growth and the prognosis of osteosarcoma. Int Orthop 1992; 16: 55-8.
20. Aho HT, Aho AJ, Einola S. Aneurysmal bone cyst, a study of ultrastructure and malignant transformation, Virch Arch A 1982; 395: 169-79.
21. Abrahamsson DH, Ellworth RM, Zimmerman LE. Nonocular cancer in retinoblastoma survivors. Trans Acad Ophthalmol Otolaryngol 1976; 81: 454-7.
22. Hansen MF. Molecular genetic considerations in osteosarcoma. Clin Orthop Rel Res 1991; 270: 181-96.
23. Dahlin DC, Goventry MB. Osteogenic sarcoma. A study of 600 cases. J Bone Joint Surg 1967; 49A: 101-110.
24. Ogihara Y, Sudo A, Fujinami S, Sato K. Miura T. Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan. Clin Orthop Rel Res 1991; 270: 72-8.
25. Aho AJ. Ekfor T, Dean PB, Aro HT, Ahonen A, Nikkanen V. Incorporation and clinical results of large allografts of the extremities and pelvis. Clin Orthop 1994; 307: 200-13.
26. Carter SR, Grimer RJ, Sneath RS. A review of 13-years experience of osteosarcoma. Clin Orthop Rel Res 1991; 270: 45-51.
27. Kotz R, Winkler K, Salzer M, et al. Surgical margins influencing oncological results in osteosarcoma. In: Yamamuro T (ed.) New Development for Limb Salvage in Musculoskeletal Tumors. Tokyo: Springer-Verlag, 1989: 83-91.
28. Simon MA, Aschliman MA, Thohas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg 1986; 68A: 1331-7.
29. Han MT, Telander RI, Pairolero PC, et al. Aggressive thoractomy for pulmonary metastatic osteogenic sarcoma in children and young adolescent. J Pediatr Surg 1981; 16: 928-33.
30. Winkler K, Bieling P, Bielack S, et al. Local control and survival from the cooperative osteosarcoma study group studies of the German society of pediatric oncology and the Vienna bone tumor registry. Clin Orthop Rel Res 1991; 270: 79-85.